2024-04-01 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd
(2024-04-01 | NDAQ:SLGL) Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Source: stockhouse.com
Page 2 - Gel Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gel Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gel Technologies Today - Breaking & Trending Today
Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream -April 01, 2024 at 07:00 am EDT
NESS ZIONA, Israel, April 01, 2024 -- Sol-Gel Technologies, Ltd. , a dermatology company pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of...
Source: marketscreener.com
Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
An ongoing phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened; Results are expected by the end of 2025 Sol-Gel ...
Source: businessinsider.com
2024-03-13 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd
(2024-03-13 | NDAQ:SLGL) Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
Source: stockhouse.com
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Sees Significant Increase in Short Interest
Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 6,600 shares, an increase of 22.2% from the December 31st total of 5,400 shares. Based on an average trading volume of 17,000 shares, […]
Source: wkrb13.com